Alpha 2.0
Login Register
» Authors » Umberto Provenzani

Umberto Provenzani

Explore the profile of Umberto Provenzani including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 508
Followers 0
Related Specialties
Psychiatry
Pharmacology
Molecular Biology
Top 10 Co-Authors
Paolo Fusar-Poli
Stefano Damiani
Pierluigi Politi
Andrea De Micheli
Philip McGuire
Natascia Brondino
Dominic Oliver
Laura Fusar-Poli
Cathy Davies
Joaquim Radua
Published In
World Psychiatry
Mol Psychiatry
Eur Neuropsychopharmacol
Front Psychiatry
Psychiatry Res
Affiliations
Soon will be listed here.
Recent Articles
1.
A systematic review and synthesis of 489 studies investigating treatments for negative symptoms in the schizophrenia spectrum: Trial designs, demographics and clinical characteristics
Damiani S, DImperio A, Radua J, Fortea L, Calo M, Crippa A, et al.
Psychiatry Res . 2025 Feb; 347:116406. PMID: 40015036
Negative symptoms in schizophrenia spectrum are associated with minimal treatment responses. The search for effective treatments is potentially hampered by heterogenous study-designs and sample characteristics depending on the intervention category....
2.
Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section
Minichino A, Davies C, Karpenko O, Christodoulou N, Ramalho R, Nandha S, et al.
Mol Psychiatry . 2025 Feb; PMID: 39953286
Recently published large-scale randomised controlled trials (RCTs) have questioned the efficacy of preventive interventions in individuals at clinical high risk for psychosis (CHR-P). We conducted a systematic review and meta-analysis...
3.
Psychological, psychiatric, and behavioral sciences measurement scales: best practice guidelines for their development and validation
Stefana A, Damiani S, Granziol U, Provenzani U, Solmi M, Youngstrom E, et al.
Front Psychol . 2025 Feb; 15:1494261. PMID: 39916786
Psychiatric, psychological, and behavioral sciences scales provide quantitative representations of phenomena such as emotions, beliefs, functioning, and social role perceptions. Methodologists and researchers have criticized current scale development practices, emphasizing...
4.
The lived experience of mental disorders in adolescents: a bottom-up review co-designed, co-conducted and co-written by experts by experience and academics
Fusar-Poli P, Estrade A, Esposito C, Rosfort R, Basadonne I, Mancini M, et al.
World Psychiatry . 2024 May; 23(2):191-208. PMID: 38727047
We provide here the first bottom-up review of the lived experience of mental disorders in adolescents co-designed, co-conducted and co-written by experts by experience and academics. We screened first-person accounts...
5.
A transdiagnostic prodrome for severe mental disorders: an electronic health record study
Arribas M, Oliver D, Patel R, Kornblum D, Shetty H, Damiani S, et al.
Mol Psychiatry . 2024 May; 29(11):3305-3315. PMID: 38710907
Effective prevention of severe mental disorders (SMD), including non-psychotic unipolar mood disorders (UMD), non-psychotic bipolar mood disorders (BMD), and psychotic disorders (PSY), rely on accurate knowledge of the duration, first...
6.
Physical Health and Transition to Psychosis in People at Clinical High Risk
De Micheli A, Provenzani U, Krakowski K, Oliver D, Damiani S, Brondino N, et al.
Biomedicines . 2024 Mar; 12(3). PMID: 38540135
Background: The clinical high risk for psychosis (CHR-P) construct represents an opportunity for prevention and early intervention in young adults, but the relationship between risk for psychosis and physical health...
7.
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Wannan C, Nelson B, Addington J, Allott K, Anticevic A, Arango C, et al.
Schizophr Bull . 2024 Mar; 50(3):496-512. PMID: 38451304
This article describes the rationale, aims, and methodology of the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). This is the largest international collaboration to date that will develop algorithms to predict...
8.
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
Davies C, Martins D, Dipasquale O, McCutcheon R, De Micheli A, Ramella-Cravaro V, et al.
Mol Psychiatry . 2024 Jan; 29(5):1241-1252. PMID: 38243074
Abnormalities in functional brain networks (functional connectome) are increasingly implicated in people at Clinical High Risk for Psychosis (CHR-P). Intranasal oxytocin, a potential novel treatment for the CHR-P state, modulates...
9.
The noise in our brain: A systematic review and meta-analysis of neuroimaging and signal-detection studies on source monitoring in psychosis
Damiani S, Cavicchioli M, Guiot C, Donadeo A, Scalabrini A, Grecuzzo V, et al.
J Psychiatr Res . 2023 Dec; 169:142-151. PMID: 38039688
Objectives: Noisy thoughts or perceptions are characteristics of psychosis (PSY) and, they are deeply related to source monitoring (SM) - the ability to discriminate the origin of internal/external experiences. Methods:...
10.
Transdiagnostic risk of mental disorders in offspring of affected parents: a meta-analysis of family high-risk and registry studies
Uher R, Pavlova B, Radua J, Provenzani U, Najafi S, Fortea L, et al.
World Psychiatry . 2023 Sep; 22(3):433-448. PMID: 37713573
The offspring of parents with mental disorders are at increased risk for developing mental disorders themselves. The risk to offspring may extend transdiagnostically to disorders other than those present in...